Volume : 13, Issue : 02, February – 2026
Title:
DEVELOPMENT AND VALIDATION OF API BY HPLC METHODS FOR THE QUALITY CONTROL TEST
Authors :
Shruti Vilas Gawai, Prof. Anjali Rathod
Abstract :
High-Performance Liquid Chromatography (HPLC) is a widely applied analytical technique for the development and validation of methods used in the quality control of Active Pharmaceutical Ingredients (APIs). Reliable analytical procedures are essential to ensure the identity, purity, potency, and stability of APIs throughout manufacturing and storage. This review discusses systematic approaches to HPLC method development, including selection of column, mobile phase optimization, detection wavelength determination, and optimization of chromatographic parameters. It further highlights essential validation characteristics such as specificity, linearity, accuracy, precision, robustness, and system suitability in accordance with regulatory guidelines. The application of HPLC in assay determination, impurity profiling, stability studies, and dissolution testing is also summarized. Recent advancements including UPLC, LC–MS integration, green analytical approaches, and automation are addressed to emphasize modern trends in pharmaceutical analysis. Overall, validated HPLC methods play a crucial role in ensuring regulatory compliance, product consistency, and patient safety in pharmaceutical quality control.
Keywords: Active Pharmaceutical Ingredient (API), High-Performance Liquid Chromatography (HPLC), Method Development, Method Validation, Quality Control, Impurity Profiling, Stability Studies, Regulatory Compliance
Cite This Article:
Please cite this article in press Shruti Vilas Gawai et al., Development And Validation Of API By HPLC Methods For The Quality Control Test, Indo Am. J. P. Sci, 2026; 13(02).
REFERENCES:
1. Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. 3rd ed. Hoboken: John Wiley & Sons; 2010.
2. Dong MW. Modern HPLC for Practicing Scientists. 2nd ed. Hoboken: John Wiley & Sons; 2019.
3. Kazakevich Y, Lobrutto R. HPLC for Pharmaceutical Scientists. Hoboken: John Wiley & Sons; 2007.
4. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Q2(R1): Validation of Analytical Procedures: Text and Methodology. Geneva: ICH; 2005.
5. Swartz ME, Krull IS. Analytical Method Development and Validation. New York: CRC Press; 2018.
6. Meyer VR. Practical High-Performance Liquid Chromatography. 5th ed. Chichester: Wiley; 2010.
7. Skoog DA, Holler FJ, Crouch SR. Principles of Instrumental Analysis. 6th ed. Belmont: Cengage Learning; 2018.
8. Snyder LR. Classification of the solvent properties of common liquids. J Chromatogr A. 1974;92:223–230.
9. Dolan JW. Peak tailing and resolution in HPLC. LCGC North America. 2002;20(9):842–849.
10. Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability-indicating studies of drugs. J Pharm Anal. 2014;4(3):159–165.
11. Bakshi M, Singh S. Development of validated stability-indicating assay methods. J Pharm Biomed Anal. 2002;28(6):1011–1040.
12. United States Food and Drug Administration (USFDA). Analytical Procedures and Methods Validation for Drugs and Biologics. Silver Spring: USFDA; 2015.
13. European Medicines Agency (EMA). Guideline on Analytical Method Validation. London: EMA; 2011.
14. International Council for Harmonisation (ICH). Q1A(R2): Stability Testing of New Drug Substances and Products. Geneva: ICH; 2003.
15. International Council for Harmonisation (ICH). Q3A(R2): Impurities in New Drug Substances. Geneva: ICH; 2006.
16. International Council for Harmonisation (ICH). Q3B(R2): Impurities in New Drug Products. Geneva: ICH; 2006.
17. Ermer J, Miller JHM. Method Validation in Pharmaceutical Analysis: A Guide to Best Practice. Weinheim: Wiley-VCH; 2005.
18. Shabir GA. Validation of high-performance liquid chromatography methods. J Chromatogr A. 2003;987(1–2):57–66.
19. Rao RN, Nagaraju V. An overview of analytical method development and validation. Indian J Pharm Sci. 2003;65(5):495–503.
20. Gorog S. Ultraviolet-visible spectrophotometry in pharmaceutical analysis. J Pharm Biomed Anal. 2005;38(2):187–199.
21. Lunn G, Sansone EB. HPLC Methods for Pharmaceutical Analysis. New York: Wiley; 1997.
22. FDA. Guidance for Industry: Q2(R1) Validation of Analytical Procedures. Silver Spring: USFDA; 2005.
23. Rozet E, Ceccato A, Hubert C, Ziemons E, Oprean R, Rudaz S, et al. Method validation in pharmaceutical analysis. J Pharm Biomed Anal. 2007;44(4):783–792.
24. Niessen WMA. Liquid Chromatography–Mass Spectrometry. 3rd ed. Boca Raton: CRC Press; 2016.
25. Swartz ME. UPLC: An introduction and review. J Liq Chromatogr Relat Technol. 2005;28(7–8):1253–1263.
26. Sandra K, Sandra P. Ultra-high-pressure liquid chromatography in pharmaceutical analysis. J Chromatogr A. 2009;1216(3):616–624.
27. Buszewski B, Noga S. Hydrophilic interaction liquid chromatography. Anal Bioanal Chem. 2012;402(1):231–247.
28. López-García I, Viñas P, Hernández-Córdoba M. Green analytical chemistry in pharmaceutical analysis. TrAC Trends Anal Chem. 2016;82:179–186.
29. Tobiszewski M, Mechlińska A, Zygmunt B, Namieśnik J. Green analytical chemistry theory and practice. Chem Soc Rev. 2010;39:2869–2878.
30. Kromidas S. The HPLC Expert: Possibilities and Limitations of Modern High Performance Liquid Chromatography. Weinheim: Wiley-VCH; 2016.
31. Snyder LR, Dolan JW, Carr PW. The hydrophobic-subtraction model of reversed-phase column selectivity. J Chromatogr A. 2004;1060(1–2):77–116.
32. Kazakevich Y. HPLC column temperature effects. LCGC North America. 2004;22(10):1124–1133.
33. European Medicines Agency (EMA). Guideline on Good Manufacturing Practice Data Integrity. London: EMA; 2018.
34. United States Pharmacopeia (USP). <1225> Validation of Compendial Procedures. Rockville: USP; 2020.
35. United States Pharmacopeia (USP). <621> Chromatography. Rockville: USP; 2022.